NCT04140448

Ultra-wide-field Fluorescein Angiography in Patients With Macular Edema Secondary to Retinal Vein Occlusion

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 60 (estimated)
• Sponsor: Renmin Hospital of Wuhan University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study mainly observed the ischemic index and vascular leakage index changes on ultra-wide field fluorescence angiography after anti-VEGF treatment , and whether these changes correlated with treatment efficacy in patients with macular edema secondary to retinal vein occlusion.

Detailed description

Ultra-wide field fluorescence angiography can clearly observe the peripheral retina. This study mainly observes the ischemic index and vascular leakage index changes on UWFA after anti-VEGF treatment and evaluates these changes associated with treatment efficacy in patients with macular edema secondary to retinal vein occlusion.

Conditions

• Retinal Vein Occlusion
• Macular Edema

Interventions

Type	Name	Description
DRUG	Ranibizumab 0.5 MG/0.05 ML Intraocular Solution [LUCENTIS]	Intravitreal injection of Ranibizumab 0.5 MG/0.05 ML
DEVICE	Ultra-wide Fluorescein Angiography	Ultra-wide-field Fluorescein Angiography can clearly observe the peripheral retina

Timeline

• Start date: 2023-10-09
• Primary completion: 2024-10-30
• Completion: 2025-12-15
• First posted: 2019-10-25
• Last updated: 2023-10-18

Locations

1 site across 1 country: China